Clinical Trial

Intraarticular Gold Microparticles for Knee Osteoarthritis

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 1, 2025 (before its estimated February 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The investigators have shown in three pilot studies that intra-articular metallic gold microparticles can reduce knee osteoarthritis pain for up to two years. These results are noteworthy considering the growing number of older adults who suffer from osteoarthritis pain, which contributes to increased demand on healthcare resources. Demonstrating effective treatment could alleviate this burden for a significant portion of the aging population. The specific aim is to evaluate whether intra-articular metallic gold microparticles are superior to placebo in reducing the need for additional treatment in patients with knee osteoarthritis within one year. The investigators will test the hypothesis that intra-articular metallic gold microparticles reduce subsequent treatment events by more than 50% compared to placebo during this period.
Trial Details
NCT Number NCT07202390
Lead Sponsor Northern Orthopaedic Division, Denmark
Collaborators: Aalborg University
Conditions Knee Osteoarthritis
Enrollment 240 participants
Start Date 2026-02-01
Primary Completion 2026-02-01 (estimated)
Study Completion 2029-02-01 (estimated)
Updated on ClinicalTrials.gov 2025-10-01